Product Information
CEFADROXIL 500 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2781 per EA under NDC 00093319653. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jan 20, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Cefadroxil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093319653
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEFADROXILApproval Type
Generic (ANDA)
FDA Application
ANDA065282FDA Approved
1/20/2006
TE Code
AB
On Market Since
1/31/2007
Pharmacological Classes
Price Statistics
The NADAC for CEFADROXIL 500 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 7.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2781 per EA |
|---|---|
| All-time high | $0.3139 (Oct 11, 2023) |
| All-time low | $0.1740 (Nov 21, 2018) |
| 52-week high | $0.3014 |
| 52-week low | $0.2762 |
| Median price | $0.2465 |
| Average price | $0.2477 |
| Largest weekly change | -29.4% (Nov 21, 2018) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFADROXIL 500 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEFADROXIL 500 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $0.2781 per EA (NDC 00093319653), effective Aug 19, 2026.
How has the price of CEFADROXIL 500 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEFADROXIL 500 MG CAPSULE has risen 7.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFADROXIL 500 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CEFADROXIL 500 MG CAPSULE has ranged from a low of $0.1740 (Nov 21, 2018) to a high of $0.3139 (Oct 11, 2023), with a median of $0.2465 per EA.
Are there cheaper alternatives to CEFADROXIL 500 MG CAPSULE?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFADROXIL 500 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFADROXIL 500 MG CAPSULE?
CEFADROXIL 500 MG CAPSULE (NDC 00093319653) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.